image
Ovid Therapeutics Inc. OVID
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.06
-7.83 %
$ 75.3 M
Market Cap
-2.59
P/E
INCOME STATEMENT
392 K REVENUE
-73.93%
Growth Rates
1Year -73.93%
3Years -68.57%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-59.3 M OPERATING INCOME
-6.72%
Growth Rates
1Year -6.72%
3Years 10.04%
5Years -2.29%
7Years -14.82%
10Years 0.00%
-52.3 M NET INCOME
3.38%
Growth Rates
1Year 3.38%
3Years 13.56%
5Years -0.14%
7Years -12.88%
10Years 0.00%
EFFICIENCY
Earnings Waterfall Ovid Therapeutics Inc.
image
Revenue 392 K
Cost Of Revenue 1.6 M
Gross Profit -1.2 M
Operating Expenses 59.7 M
Operating Income -59.3 M
Other Expenses -6.94 M
Net Income -52.3 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014
REVENUE
Revenue 0.4 1.5 208.4 12.6 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 1.6 1.4 0 0 0.3 0.1 80.3 K 56.5 K 11.8 K 0
Gross Profit (1.2) 0.1 208.4 12.6 (0.3) (0.1) 80.3 K 56.5 K 11.8 K 0
OPERATING INCOME
Operating Expenses 59.7 57.1 84.2 94.0 61.4 52.9 65.0 22.5 13.2 0.4
Selling, General and Administrative Expenses 31.1 32.4 37.2 30.6 19.3 19.1 15.0 12.9 6.6 0.3
Research and Development Expenses 28.6 24.6 46.9 63.4 42.2 33.8 50.0 9.6 6.6 0.1
Operating Income (59.3) (55.5) 124.2 (81.4) (61.4) (52.9) (65.0) (22.5) (13.2) (0.4)
PRE-TAX INCOME
Interest Income Expense 0 (2.8) 0 0 0 0 0 0 0 0
Total Other Income 6.9 1.4 45.7 K 0.4 0.9 1.0 0.2 0.1 30.3 K 0
Pre-Tax Income (52.3) (54.2) 124.2 (81.0) (60.5) (52.0) (64.8) (22.4) (13.2) (0.4)
NET INCOME
Tax Provision 0 (2.8) 1.3 (0.3) (1.2) 1.0 80.3 K 950 0 0
Net Income (52.3) (51.4) 122.8 (80.7) (59.3) (52.0) (64.8) (22.4) (13.2) (0.4)
EPS 0.74 0.73 1.78 1.38 1.51 2.11 3.35 1.14 0.67 0.094